Первый Санкт-Петербургский государственный медицинский университет имени И. П. Павлова — федеральное государственное бюджетное образовательное учреждение высшего образования Министерства здравоохранения Российской Федерации. До сегодняшнего дня вуз сменил несколько названий: Женский медицинский институт.

During the past decade, Saint Petersburg State Institution of Healthcare City Geriatric Medico-Social Center conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 9 clinical trials were completed, i.e. on average, 128.6% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 5 clinical trials were completed. i.e. 166.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saint Petersburg State Institution of Healthcare City Geriatric Medico-Social Center" #1 sponsor was "Hoffmann-La Roche" with 3 trials, followed by "Boehringer Ingelheim" with 2 trials sponsored, "Materia Medica Holding" with 2 trials sponsored, "RSV Therapeutics LLC" with 2 trials sponsored and "Sunovion" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saint Petersburg State Institution of Healthcare City Geriatric Medico-Social Center" #1 collaborator was "BioInvent International AB" with 2 trials as a collaborator and "Covance" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Saint Petersburg State Institution of Healthcare City Geriatric Medico-Social Center" are "Alzheimer Disease" (2 trials), "Alzheimer's Disease" (2 trials), "Obesity" (2 trials), "Psoriasis" (2 trials) and "Bipolar I Disorder" (1 trials). Many other conditions were trialed in "Saint Petersburg State Institution of Healthcare City Geriatric Medico-Social Center" in a lesser frequency.

Most popular intervention types in "Saint Petersburg State Institution of Healthcare City Geriatric Medico-Social Center" are "Drug" (16 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Gantenerumab" (3 trials), "BI 695501" (2 trials), "Dietressa" (2 trials) and "TB-402" (2 trials). Other intervention names were less common.

The vast majority of trials in "Saint Petersburg State Institution of Healthcare City Geriatric Medico-Social Center" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Saint Petersburg State Institution of Healthcare City Geriatric Medico-Social Center". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Saint Petersburg State Institution of Healthcare City Geriatric Medico-Social Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Saint Petersburg State Institution of Healthcare City Geriatric Medico-Social Center, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".